Compound 2005
Identifiers
- Canonical SMILES:
Cc1ccsc1C(=O)NN=Cc1ccc2ccccc2c1O
- IUPAC name:
N'-[(1-hydroxynaphthalen-2-yl)methylidene]-3-methylthiophene-2-carbohydrazide
- InChi:
InChI=1S/C17H14N2O2S/c1-11-8-9-22-16(11)17(21)19-18-10-13-7-6-12-4-2-3-5-14(12)15(13)20/h2-10,20H,1H3,(H,19,21)
- InChiKey:
NZWTWRNHYZNWNW-UHFFFAOYSA-N
External links
![]() 831824 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 22 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
PCNA trimer | 9.74 | Stabilization |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 310.08 g/mol | |||
HBA | 4 | |||
HBD | 2 | |||
HBA + HBD | 6 | |||
AlogP | 4.08 | |||
TPSA | 61.69 | |||
RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 22 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1124/mol.112.077735 | PCNA-I1 | PCNA P12004 |
|
Biochemical assay | microscale thermophoresis | pKd (dissociation constant, -log10) | 6.39 | |
10.1124/mol.112.077735 | PCNA-I1 | PCNA P12004 |
|
Biochemical assay | Surface Plasmon Resonance | pKd (dissociation constant, -log10) | 6.85 | |
10.1124/mol.112.077735 | PCNA-I1 | PCNA P12004 |
|
Cellular assay | cell growth inhibition MCF-7 | MCF7 mammary carcinoma cells | pIC50 (half maximal inhibitory concentration, -log10) | 6.82 |
10.1124/mol.112.077735 | PCNA-I1 | PCNA P12004 |
|
Cellular assay | cell growth inhibition T47D | T47D | pIC50 (half maximal inhibitory concentration, -log10) | 6.82 |
10.1124/mol.112.077735 | PCNA-I1 | PCNA P12004 |
|
Cellular assay | cell growth inhibition PC-3 | PC-3 | pIC50 (half maximal inhibitory concentration, -log10) | 6.62 |
10.1124/mol.112.077735 | PCNA-I1 | PCNA P12004 |
|
Cellular assay | cell growth inhibition DU145 | DU145 | pIC50 (half maximal inhibitory concentration, -log10) | 6.80 |
10.1124/mol.112.077735 | PCNA-I1 | PCNA P12004 |
|
Cellular assay | cell growth inhibition 22Rv1 | 22Rv1 | pIC50 (half maximal inhibitory concentration, -log10) | 9.74 |
10.1124/mol.112.077735 | PCNA-I1 | PCNA P12004 |
|
Cellular assay | cell growth inhibition LAPC-4 | LAPC-4 | pIC50 (half maximal inhibitory concentration, -log10) | 6.52 |
10.1124/mol.112.077735 | PCNA-I1 | PCNA P12004 |
|
Cellular assay | cell growth inhibition LNCaP | LNCaP | pIC50 (half maximal inhibitory concentration, -log10) | 6.85 |
10.1124/mol.112.077735 | PCNA-I1 | PCNA P12004 |
|
Cellular assay | cell growth inhibition A375 | A375 | pIC50 (half maximal inhibitory concentration, -log10) | 6.80 |
10.1124/mol.112.077735 | PCNA-I1 | PCNA P12004 |
|
Cellular assay | cell growth inhibition MDA-MDB435 | MDA-MDB435 | pIC50 (half maximal inhibitory concentration, -log10) | 6.54 |
10.1124/mol.112.077735 | PCNA-I1 | PCNA P12004 |
|
Cellular assay | cell growth inhibition TRAMP-C2RE3 | TRAMP-C2RE3 | pIC50 (half maximal inhibitory concentration, -log10) | 6.70 |
10.1124/mol.112.077735 | PCNA-I1 | PCNA P12004 |
|
Cellular assay | cell growth inhibition B16 | B16 | pIC50 (half maximal inhibitory concentration, -log10) | 6.85 |
10.1124/mol.112.077735 | PCNA-I1 | PCNA P12004 |
|
Cellular assay | cell growth inhibition K1735 | K1735 | pIC50 (half maximal inhibitory concentration, -log10) | 7.30 |
10.1124/mol.112.077735 | PCNA-I1 | PCNA P12004 |
|
Cellular assay | cell growth inhibition UV2237 | UV2237 | pIC50 (half maximal inhibitory concentration, -log10) | 6.60 |
10.1124/mol.112.077735 | PCNA-I1 | PCNA P12004 |
|
Cellular assay | cell growth inhibition CT26-P | CT26-P | pIC50 (half maximal inhibitory concentration, -log10) | 6.89 |
10.1124/mol.112.077735 | PCNA-I1 | PCNA P12004 |
|
Cellular assay | cell growth inhibition CT26-R100 | CT26-R100 | pIC50 (half maximal inhibitory concentration, -log10) | 7.10 |
10.1124/mol.112.077735 | PCNA-I1 | PCNA P12004 |
|
Cellular assay | cell growth inhibition CT26-R500 | CT26-R500 | pIC50 (half maximal inhibitory concentration, -log10) | 7.15 |
10.1124/mol.112.077735 | PCNA-I1 | PCNA P12004 |
|
Cellular assay | cell growth inhibition HUVEC | HUVEC | pIC50 (half maximal inhibitory concentration, -log10) | 5.81 |
10.1124/mol.112.077735 | PCNA-I1 | PCNA P12004 |
|
Cellular assay | cell growth inhibition human mesenchymal stem cells | human mesenchymal stem cells | pIC50 (half maximal inhibitory concentration, -log10) | 6.00 |
10.1124/mol.112.077735 | PCNA-I1 | PCNA P12004 |
|
Cellular assay | cell growth inhibition human breast epithelial cells | human breast epithelial cells | pIC50 (half maximal inhibitory concentration, -log10) | 5.78 |
10.1124/mol.112.077735 | PCNA-I1 | PCNA P12004 |
|
Cellular assay | cell growth inhibition human prostate epithelial cells | human prostate epithelial cells | pIC50 (half maximal inhibitory concentration, -log10) | 5.70 |
10.1124/mol.112.077735 | PCNA-I1 | PCNA P12004 |
|
Cellular assay | cell growth inhibition mouse bone marrow stroma cells | mouse bone marrow stroma cells | pIC50 (half maximal inhibitory concentration, -log10) | 5.72 |
10.1124/mol.112.077735 | PCNA-I1 | PCNA P12004 |
|
Cellular assay | cell growth inhibition mouse spleen lymphocytes | mouse spleen lymphocytes | pIC50 (half maximal inhibitory concentration, -log10) | 5.82 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5454 | N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]naphthalene-2-carbohydrazide | DB06949 | |
0.5242 | 3-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide | DB07044 | |
0.5242 | 4-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide | DB07098 | |
0.5161 | (E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE | DB08034 | |
0.5118 | 4-tert-butyl-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide | DB07097 | |
0.5039 | N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]-4-methoxybenzohydrazide | DB06978 | |
0.4962 | 4-chloro-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide | DB06950 | |
0.4514 | N'-[(1E)-(3,5-DIBROMO-2,4-DIHYDROXYPHENYL)METHYLENE]NICOTINOHYDRAZIDE | DB07445 | |
0.3862 | PAC-1 | DB13048 | |
0.3667 | Benzo[B]Thiophene-2-Carboxamidine | DB04446 | |
0.3518 | N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide | DB08235 | |
0.3448 | 3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol | DB03996 | |
0.3448 | Nifurzide | DB13325 | |
0.3392 | Nifuroxazide | DB13855 | |
0.3352 | N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide | DB07812 |